These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Poxvirus Vaccines: Past, Present, and Future. Jhancy M Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584 [TBL] [Abstract][Full Text] [Related]
3. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox. Meseda CA; Weir JP Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482 [TBL] [Abstract][Full Text] [Related]
4. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks. Handley L; Buller RM; Frey SE; Bellone C; Parker S Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111 [TBL] [Abstract][Full Text] [Related]
5. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ; MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832 [TBL] [Abstract][Full Text] [Related]
6. [Biohazards due to Orthopoxvirus: should we re-vaccinate against smallpox?]. Georges AJ; Georges-Courbot MC Med Trop (Mars); 1999; 59(4 Pt 2):483-7. PubMed ID: 10901851 [TBL] [Abstract][Full Text] [Related]
7. Smallpox, Monkeypox and Other Human Orthopoxvirus Infections. Shchelkunova GA; Shchelkunov SN Viruses; 2022 Dec; 15(1):. PubMed ID: 36680142 [TBL] [Abstract][Full Text] [Related]
8. Smallpox vaccination and bioterrorism with pox viruses. Mayr A Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):423-30. PubMed ID: 12818626 [TBL] [Abstract][Full Text] [Related]
9. The strategic use of novel smallpox vaccines in the post-eradication world. Golden JW; Hooper JW Expert Rev Vaccines; 2011 Jul; 10(7):1021-35. PubMed ID: 21806397 [TBL] [Abstract][Full Text] [Related]
12. Clinical guidance for smallpox vaccine use in a postevent vaccination program. Petersen BW; Damon IK; Pertowski CA; Meaney-Delman D; Guarnizo JT; Beigi RH; Edwards KM; Fisher MC; Frey SE; Lynfield R; Willoughby RE MMWR Recomm Rep; 2015 Feb; 64(RR-02):1-26. PubMed ID: 25695372 [TBL] [Abstract][Full Text] [Related]
13. Protection of mice against the highly pathogenic VV Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905 [TBL] [Abstract][Full Text] [Related]
14. [We should be prepared to smallpox re-emergence.]. Shchelkunov SN; Shchelkunova GA Vopr Virusol; 2019; 64(5):206-214. PubMed ID: 32167685 [TBL] [Abstract][Full Text] [Related]
15. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge. Mucker EM; Golden JW; Hammerbeck CD; Kishimori JM; Royals M; Joselyn MD; Ballantyne J; Nalca A; Hooper JW J Virol; 2022 Feb; 96(3):e0150421. PubMed ID: 34851148 [TBL] [Abstract][Full Text] [Related]
16. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies. Wiser I; Balicer RD; Cohen D Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424 [TBL] [Abstract][Full Text] [Related]
17. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997 [TBL] [Abstract][Full Text] [Related]
18. Controlling orthopoxvirus infections--200 years after Jenner's revolutionary immunization. Niemiałtowski MG; Toka FN; Malicka E; Gieryńska ; Spohr de Faundez I; Schollenberger A Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):373-8. PubMed ID: 9017154 [TBL] [Abstract][Full Text] [Related]
19. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development. Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360 [TBL] [Abstract][Full Text] [Related]
20. The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data. Keckler MS; Reynolds MG; Damon IK; Karem KL Vaccine; 2013 Oct; 31(45):5192-201. PubMed ID: 23994378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]